HSV-2 Biochip concerns the evaluation of an innovative HSV-2 antibody biosensor designed & developed at MiCRA Biodiagnostics for use in PoC immunoassay devices & mobile bio-analytical systems. The chip R&D & clinical analysis under review will correlate the biosensor response against known positive and negative human serum samples held by a commercial reference laboratory, viz Cerba Specimen Servi (Q233162)
Jump to navigation
Jump to search
Project in Ireland financed by DG Regio
Language | Label | Description | Also known as |
---|---|---|---|
English | HSV-2 Biochip concerns the evaluation of an innovative HSV-2 antibody biosensor designed & developed at MiCRA Biodiagnostics for use in PoC immunoassay devices & mobile bio-analytical systems. The chip R&D & clinical analysis under review will correlate the biosensor response against known positive and negative human serum samples held by a commercial reference laboratory, viz Cerba Specimen Servi |
Project in Ireland financed by DG Regio |
Statements
7,683.84 Euro
0 references
15,367.68 Euro
0 references
50.0 percent
0 references
27 July 2015
0 references
26 December 2015
0 references
Institute of Technology, Tallaght
0 references
HSV-2 Biochip concerns the evaluation of an innovative HSV-2 antibody biosensor designed & developed at MiCRA Biodiagnostics for use in PoC immunoassay devices & mobile bio-analytical systems. The chip R&D & clinical analysis under review will correlate the biosensor response against known positive and negative human serum samples held by a commercial reference laboratory, viz Cerba Specimen Services, Paris. (English)
0 references
Identifiers
119
0 references